SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-037041
Filing Date
2014-02-05
Accepted
2014-02-05 17:06:33
Documents
7
Period of Report
2014-02-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d665596d8k.htm 8-K 17997
2 EX-1.1 d665596dex11.htm EX-1.1 180694
3 EX-4.1 d665596dex41.htm EX-4.1 62215
4 EX-5.1 d665596dex51.htm EX-5.1 13362
5 EX-99.1 d665596dex991.htm EX-99.1 8711
6 GRAPHIC g665596gra1.jpg GRAPHIC 13762
7 GRAPHIC g665596img2.jpg GRAPHIC 3137
  Complete submission text file 0001193125-14-037041.txt   307778
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 14576884
SIC: 2836 Biological Products, (No Diagnostic Substances)